Drug Shortage Report for ACT AMPHETAMINE XR

Last updated on 2019-01-31 History
Report ID 68265
Drug Identification Number 02439247
Brand name ACT AMPHETAMINE XR
Common or Proper name AMPHETAMINE XR
Company Name TEVA CANADA LIMITED
Active Ingredient(s) DEXTROAMPHETAMINE SACCHARATE DEXTROAMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE AMPHETAMINE SULFATE
Strength(s) 2.5MG 2.5MG 2.5MG 2.5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-30
Estimated end date 2019-01-30
Actual end date 2019-01-30
Shortage status Resolved
Updated date 2019-01-31
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-01-31 French Compare
v4 2019-01-31 English Compare
v3 2018-12-01 English Compare
v2 2018-11-30 French Compare
v1 2018-11-30 English Compare